Neurocrine Biosciences Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

850,632

Value ($000)

120,645

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	120,645	0.0%	850,632	12/31/2025
2025 Q3	11/10/2025	116,452	0.0%	829,547	9/30/2025
2025 Q2	8/12/2025	99,259	0.0%	789,715	6/30/2025
2025 Q1	9/15/2025	85,800	0.0%	775,773	3/31/2025
2024 Q4	2/6/2025	104,089	0.0%	762,557	12/31/2024
2024 Q3	11/12/2024	86,103	0.0%	747,291	9/30/2024
2024 Q2	8/12/2024	103,597	0.0%	752,501	6/30/2024
2024 Q1	5/9/2024	100,017	0.0%	725,178	3/31/2024
2023 Q4	2/6/2024	90,497	0.0%	686,835	12/31/2023
2023 Q3	11/8/2023	70,118	0.0%	623,267	9/30/2023
2023 Q2	8/10/2023	57,045	0.0%	604,933	6/30/2023
2023 Q1	5/12/2023	59,152	0.0%	584,392	3/31/2023
2022 Q4	2/13/2023	67,608	0.0%	566,039	12/31/2022
2022 Q3	11/14/2022	57,458	0.0%	540,976	9/30/2022
2022 Q2	8/15/2022	51,958	0.0%	533,001	6/30/2022
2022 Q1	5/13/2022	48,830	0.0%	520,849	3/31/2022
2021 Q4	2/11/2022	43,404	0.0%	509,615	12/31/2021
2021 Q3	11/16/2021	47,674	0.0%	497,068	9/30/2021
2021 Q2	8/16/2021	46,680	0.0%	479,649	6/30/2021
2021 Q1	5/17/2021	45,423	0.0%	467,070	3/31/2021
2020 Q4	2/16/2021	45,483	0.0%	474,521	12/31/2020
2020 Q3	11/13/2020	45,247	0.0%	470,532	9/30/2020
2020 Q2	8/20/2020	56,423	0.0%	462,482	6/30/2020
2020 Q1	5/15/2020	39,124	0.0%	452,029	3/31/2020
2019 Q4	2/7/2020	47,455	0.0%	441,477	12/31/2019
2014 Q2	7/30/2014	2,969	0.0%	200,019	6/30/2014
2014 Q1	4/29/2014	3,021	0.0%	187,631	3/31/2014
2013 Q4	2/14/2014	1,707	0.0%	182,739	12/31/2013